NewsRx

Search our medical news database

Obstetrics

BMP Sunstone Receives Import Drug License (IDL) from SFDA

Published in Drug Week, June 13th, 2008

BMP Sunstone Corporation (NASDAQ:BJGP) (''BMP Sunstone'' or the ''Company'') announced that it has received an Import Drug License (IDL) from the SFDA to market a new Propess applicator in China.

Prior to today in China, Propess was indicated for cervix dilation to help induce labor, and is currently distributed via vaginal inserts that are 1.1 mm thick. The birth rate in China averages approximately 1.2%, which results in about 16 million births each year. Further, about 18% of pregnant women require cervical dilation, including 3% of women with Premature Rupture of Membranes (PROM).

The IDL approved today will enable BMP Sunstone to market and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook